Corcept Therapeutics (CORT) Inventory (2012 - 2026)

Corcept Therapeutics has disclosed Inventory across 15 years of filings, most recently posting $12.9 million for Q1 2026.

• Inventory for Q1 2026 came in at $12.9 million, down 10.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (down 10.29% YoY), and the FY2025 annual result was $12.9 million, up 3.67% from the prior year.
• Inventory came in at $12.9 million for Q1 2026 at Corcept Therapeutics, roughly flat from $12.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $14.4 million in Q1 2025 to a low of $5.1 million in Q1 2022.
• The 5-year median for Inventory is $7.7 million (2023), against an average of $8.9 million.
• Across the five-year window, Inventory surged 99.83% in 2025 and dropped 10.29% in 2026, its largest moves.
• Corcept Therapeutics' Inventory stood at $6.1 million in 2022, then grew by 26.72% to $7.7 million in 2023, then soared by 60.57% to $12.4 million in 2024, then gained by 3.67% to $12.9 million in 2025, then increased by 0.17% to $12.9 million in 2026.
• The last three Inventory figures came in at $12.9 million (Q1 2026), $12.9 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.